JP2009544971A5 - - Google Patents

Download PDF

Info

Publication number
JP2009544971A5
JP2009544971A5 JP2009521844A JP2009521844A JP2009544971A5 JP 2009544971 A5 JP2009544971 A5 JP 2009544971A5 JP 2009521844 A JP2009521844 A JP 2009521844A JP 2009521844 A JP2009521844 A JP 2009521844A JP 2009544971 A5 JP2009544971 A5 JP 2009544971A5
Authority
JP
Japan
Prior art keywords
iga
autoantibodies
serum
complex
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009521844A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009544971A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/016853 external-priority patent/WO2008013914A2/en
Publication of JP2009544971A publication Critical patent/JP2009544971A/ja
Publication of JP2009544971A5 publication Critical patent/JP2009544971A5/ja
Pending legal-status Critical Current

Links

JP2009521844A 2006-07-26 2007-07-26 急性アテローム硬化症候群を有する患者を診断するための組成物および方法 Pending JP2009544971A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83375706P 2006-07-26 2006-07-26
US91822507P 2007-03-14 2007-03-14
PCT/US2007/016853 WO2008013914A2 (en) 2006-07-26 2007-07-26 Compositions and methods for diagnosing patients with acute atherosclerotic syndromes

Publications (2)

Publication Number Publication Date
JP2009544971A JP2009544971A (ja) 2009-12-17
JP2009544971A5 true JP2009544971A5 (enExample) 2010-03-11

Family

ID=38982086

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009521844A Pending JP2009544971A (ja) 2006-07-26 2007-07-26 急性アテローム硬化症候群を有する患者を診断するための組成物および方法

Country Status (6)

Country Link
US (2) US7745146B2 (enExample)
EP (1) EP2047263A4 (enExample)
JP (1) JP2009544971A (enExample)
AU (1) AU2007277146B2 (enExample)
CA (1) CA2658824A1 (enExample)
WO (1) WO2008013914A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009544971A (ja) * 2006-07-26 2009-12-17 イノヴァ ダイアグノスティクス インコーポレイテッド 急性アテローム硬化症候群を有する患者を診断するための組成物および方法
MX2009006744A (es) * 2006-12-22 2009-06-30 Abbott Lab Panel de padecimiento cardiovascular autoinmune y metodos de utilizacion del mismo.
JP5461581B2 (ja) * 2009-01-02 2014-04-02 フライサン ディベロップメント カンパニー リミテッド 自己免疫疾患を診断するための合成ペプチド、方法およびキット
EP2580593A4 (en) * 2010-06-10 2014-04-16 Myra Lipes DIAGNOSIS OF MYOCARDIAL AUTOIMMUNITY IN HEART DISEASES
JP5904553B2 (ja) * 2010-11-17 2016-04-13 国立大学法人愛媛大学 自己免疫疾患に関与するタンパク質の解析方法及び該疾患の検査方法
CN102156190A (zh) * 2010-12-31 2011-08-17 深圳市亚辉龙生物科技有限公司 一种测定抗β2糖蛋白I抗体IgG/A/M的方法及试剂装置
JP6399987B2 (ja) * 2015-09-11 2018-10-03 ヤマサ醤油株式会社 抗β2−GPI抗体の測定法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0250119A3 (en) * 1986-06-20 1990-04-18 Vasocor Atherosclerotic anti-idiotype antibody immunoassay and reagents
IL84160A0 (en) * 1986-10-16 1988-03-31 Vasocor Method and kit for immune complex assay
US4981785A (en) 1988-06-06 1991-01-01 Ventrex Laboratories, Inc. Apparatus and method for performing immunoassays
US5376313A (en) 1992-03-27 1994-12-27 Abbott Laboratories Injection molding a plastic assay cuvette having low birefringence
WO1995014231A1 (en) * 1993-11-16 1995-05-26 Yamasa Corporation Method of assaying antiphospholipid antibody and kit therefor
CA2239957A1 (en) 1995-12-22 1997-07-03 Abbott Laboratories Fluorescence polarization immunoassay diagnostic method
US5885529A (en) 1996-06-28 1999-03-23 Dpc Cirrus, Inc. Automated immunoassay analyzer
US6585210B1 (en) 2002-06-19 2003-07-01 Super Link Electronics Co., Ltd. Secure pen holding mechanism
SI1735349T1 (sl) * 2004-04-15 2010-12-31 Athera Biotechnologies Ab Postopek ocenitve tveganja ishemske kardiovaskularne bolezni z uporabo fosforilholinskih konjugatov
JP2009544971A (ja) * 2006-07-26 2009-12-17 イノヴァ ダイアグノスティクス インコーポレイテッド 急性アテローム硬化症候群を有する患者を診断するための組成物および方法

Similar Documents

Publication Publication Date Title
Kamada et al. Serum Mac‐2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis
Ladd et al. Autoantibody signatures involving glycolysis and splicesome proteins precede a diagnosis of breast cancer among postmenopausal women
JP2010536043A5 (enExample)
JP2014508298A5 (enExample)
Wasilewska et al. Markers of systemic inflammation in children with hyperuricemia
DK1739430T3 (da) Fremgangsmåde til assay af cardiovaskulære sygdomme
WO2010038974A3 (ko) 이뮤노글로블린 에이 신증과 티지비엠 신증의 진단용 조성물 및 키트
JP2012509477A5 (enExample)
WO2010002911A3 (en) Methods and materials for monitoring myeloma using quantitative mass spetrometry
JP2013511735A5 (enExample)
Lee et al. Hypertransaminasemia in newly diagnosed pediatric patients with celiac disease
Moon et al. Surface‐independent and oriented immobilization of antibody via one‐step polydopamine/protein G coating: application to influenza virus immunoassay
WO2008109075A3 (en) Biomarkers and methods for determining sensitivity to ctla-4 antagonists
Launoy et al. Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average‐risk population
Carrigan et al. Real-time QCM-D immunoassay through oriented antibody immobilization using cross-linked hydrogel biointerfaces
JP2007506945A5 (enExample)
Evtugyn et al. Affinity biosensors for detection of mycotoxins in food
Kapoor Cholecystectomy in patients with asymptomatic gallstones to prevent gall bladder cancer--the case against.
Chan et al. Use of hepatitis B virus core‐related antigen to evaluate natural history of chronic hepatitis B
JP5810267B2 (ja) プラズモンセンサとその使用方法及び製造方法
Jiao et al. Identification of potential biomarkers by serum proteomics analysis in rats with sepsis
JP2010526995A5 (enExample)
WO2008136510A1 (ja) 自己免疫性膵炎及び劇症1型糖尿病の検査方法及び検査試薬
WO2010006199A3 (en) Immunoassays for the detection of anti -non-muscle myosin heavy chain (nmhc)-ii autoantibodies in cardiovascular diseases
Beneduce et al. Tumour‐specific induction of immune complexes: DCP‐IgM in hepatocellular carcinoma